Alternatively, an immunohistochemical analysis in BRCA1-associated and sporadic triple-negative breast cancer (TNBC) showed that there was no significant difference in PD-L1 expression in TNBC between BRCA1 carriers and noncarriers49. This evidence concerns the gene BRCA1 and triple-negative breast carcinoma.